- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05365139
Diagnostic Tools for Identifying Prolonged Grief
Diagnostic Tools for Identifying Prolonged Grief: Development and Validation of the First Clinical Diagnostic Interview for Assessing Prolonged Grief Disorder With the ICD 11 Criteria and DSM-5 Tr Criteria.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Development and validation of first clinical diagnostic interview for assessing Prolonged Grief Disorder (PGD) with the ICD 11 and DSM 5 Tr criteria.
Background: With WHO's introduction of PGD in the ICD 11, which will be implemented in Health Services worldwide from January 2022, there is a need to accurately diagnose people with ICD-11PGD (PGD caseness) with a valid structured clinical interview.
With ICD-11 a slightly different set of symptoms for PGD is defined as the gold standard for PGD. This standard will be used for diagnosing and understanding PGD in future research and health service. ICD-11 aims to be descriptive, e.g. provides a support for the clinicians to identify PGD by describing common reactions and symptoms of this disorder, but there is still a need to evaluate the validity of these criteria. Strict diagnostic criteria with defined numbers, combinations, and intensity of symptoms (e.g. for the use in research) are not yet defined in ICD-11 and no structured clinical interview that measure ICD-11 or the upcoming DSM 5 tr PGD has yet been developed and validated for this purpose. This means that the field currently stand without reliable ways to classify accurately who has PGD diagnosis and who has not. Without such constructs, PGD is not possible to identify, and ultimately to treat, in a validated and reliable way.
There is therefore a need to develop accurate tests that measure ICD 11 PGD, both in a structured clinical interview for use in direct meetings between patients and health service professionals and in relation to a self-report scale. The investigators already developed the Aarhus PGD scale but still need a structured clinical interview.
Aim: In this project we will
- Develop and validate the first structured, clinical interview for ICD-11 PGD and DSM-5 Tr PGD
- Identify a valid clinical cut-off for diagnostic PGD on The Aarhus PGD Scale.
Method:
Based on the ICD-11 and DSM 5 Tr PGD criteria and our work with the self-report scale above the investigators will develop a structured, clinical interview, The Aarhus PGD Interview, in line with the strategy used in SCID-I interviews [6]. This study will examine the content validity, the concurrent validity, the test-retest reliability and the inter-rater reliability of this interview.
After the Aarhus PGD Interview is validated, this study will compare the participant's scores on the Aarhus PGD Scale for ICD 11 and DSM 5 Tr PGD with the clinical interview as the gold standard. This will allow investigating the diagnostic test accuracy of the ICD-11 PGD scale, and to identify a valid clinical cut-off on this scale.
Perspectives: The main aim of this study is to develop and validate the first structured, clinical interview for ICD 11 and DSM 5 Tr PGD. It will provide reliable constructs to separate PGD from other, trans-diagnostic forms of complicated grief reactions such as PTSD, depression and anxiety following a loss. The ability to identify who actually has a diagnosis of PGD and are in need of treatment is crucial to be able to allocate health benefits as efficient and helpful as possible. It is also crucial in identifying the vast majority of bereaved people with normal grief reactions, and to reduce the risk of pathologizing healthy grief, which is a concern brought on by the introduction of PGD as a diagnostic entity
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Maja O'Connor
- Phone Number: +4529870779
- Email: maja@psy.au.dk
Study Contact Backup
- Name: Christina Buur Steffensen
- Phone Number: +4529241045
- Email: Buur@psy.au.dk
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Recruiting
- Aarhus University
-
Contact:
- Maja O'Connor
- Phone Number: 29870779
- Email: maja@psy.au.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Bereaved by the loss a loved one to death minimum 6 month ago
- 18 years or above
- The grief is still (more or less) affecting function/everyday life
Exclusion Criteria:
- Bereaved by other losses than a loved person (e.g., pet, divorce)
- 17 years or younger
- Less than 6 month ago since the loss.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prolonged grief disorder (ICD-11 and DSM-TR)
Time Frame: 1 day
|
The Aarhus PGD-interview (dichotomous scoring 0/1 (1 equals worse outcome))
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post traumatic stress disorder
Time Frame: 1 day
|
the MINI interview adapted to DSM-5 PTSD criteria (structured clinical interview, dichotomous scoring 0/1 (1 equals worse outcome))
|
1 day
|
Depression and generalized anxiety disorder
Time Frame: 1 day
|
The Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (semi-structrured clinical interview, dichotomous scoring 0/1 (1 equals worse outcome))
|
1 day
|
The Aarhus PGD-Scale
Time Frame: 1 day
|
Self report questionnaire based on 26 5-point Likert scale items (higher scores equals worse outcome)
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Maja O'Connor, Aarhus Universitet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35880 Aarhus University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prolonged Grief Disorder
-
Koç UniversityRecruiting
-
Rigshospitalet, DenmarkRecruitingProlonged Grief DisorderDenmark
-
University Hospital, CaenInstitut National de la Santé Et de la Recherche Médicale, France; Université... and other collaboratorsEnrolling by invitationProlonged Grief DisorderFrance
-
Columbia UniversityNational Institute of Mental Health (NIMH); Center for Psychological ConsultationCompleted
-
ISPA - Instituto Universitario de Ciencias Psicologicas...RecruitingGrief Disorder, ProlongedPortugal
-
Debrot AnikCompletedProlonged Grief DisorderSwitzerland
-
Uppsala UniversityCompletedProlonged Grief DisorderSweden
-
University of ArizonaCompleted
-
VA Office of Research and DevelopmentCompletedProlonged Grief DisorderUnited States
-
Medical College of WisconsinRecruiting
Clinical Trials on Structured clinical diagnostic interview for PGD (PGD-I)
-
University of Milano BicoccaUniversity of MilanCompletedGeneralized Anxiety Disorder | Panic Disorder | Duration of Untreated IllnessItaly
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Lung Cancer | Anxiety DisorderUnited States
-
Medical University InnsbruckUnknownEating DisordersAustria
-
Dufresne, Craig, MD, PCRecruitingFreeman-Sheldon Syndrome | Whistling Face Syndrome | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Gordon Syndrome | Arthrogryposis Distal Type 3 | Arthrogryposis Distal Type 1 | Freeman-Burian SyndromeUnited States
-
Freeman-Sheldon Research Group, Inc.TerminatedCraniofacial Abnormalities | Arthrogryposis | Freeman-Sheldon Syndrome | Arthrogryposis Distal Type 2A | Whistling Face Syndrome | Craniocarpotarsal Dysplasia | Craniocarpotarsal Dystrophy | Freeman-Sheldon Syndrome Variant | Sheldon-Hall Syndrome | Arthrogryposis Distal Type 2B | Gordon Syndrome | Arthrogryposis... and other conditionsUnited States